S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Are Gene Therapy Stocks The Market's Next Big Winners?
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
NASDAQ:OMCL

Omnicell (OMCL) Stock Forecast, Price & News

$48.50
-1.32 (-2.65%)
(As of 09/25/2023 ET)
Compare
Today's Range
$47.97
▼
$49.91
50-Day Range
$48.50
▼
$67.48
52-Week Range
$46.11
▼
$91.99
Volume
557,512 shs
Average Volume
493,197 shs
Market Capitalization
$2.19 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$68.75
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Omnicell MarketRank™ Forecast

Analyst Rating
Hold
2.29 Rating Score
Upside/​Downside
41.8% Upside
$68.75 Price Target
Short Interest
Healthy
4.87% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.41mentions of Omnicell in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
50.68%
From $0.73 to $1.10 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Medical Sector

275th out of 963 stocks

Electronic Computers Industry

4th out of 5 stocks

See Top Rated MarketRank™ Stocks Here

OMCL stock logo

About Omnicell (NASDAQ:OMCL) Stock

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.

OMCL Price History

OMCL Stock News Headlines

September 18, 2023 | finance.yahoo.com
An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 32% Undervalued
September 16, 2023 | money.usnews.com
Omnicell, Inc.
September 26, 2023 | Legacy Research (Ad)
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk
I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.
September 6, 2023 | finance.yahoo.com
Here's Why You Should Retain Omnicell (OMCL) Stock Now
September 5, 2023 | finance.yahoo.com
Unveiling Omnicell (OMCL)'s Value: Is It Really Priced Right? A Comprehensive Guide
August 30, 2023 | benzinga.com
Omnicell Inc. Unusual Options Activity: Slightly OTM Call Buying With Relative Size
August 25, 2023 | seekingalpha.com
Omnicell: Slowdown In Core Markets, Backlog Pressures Support Neutral Posture
August 23, 2023 | markets.businessinsider.com
Craig-Hallum Sticks to Their Buy Rating for Omnicell (OMCL)
September 26, 2023 | Behind the Markets (Ad)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
August 23, 2023 | finance.yahoo.com
Omnicell to Present at the 2023 Wells Fargo Healthcare Conference
August 10, 2023 | seekingalpha.com
Omnicell, Inc. 2023 Q2 - Results - Earnings Call Presentation
August 2, 2023 | insidermonkey.com
Omnicell, Inc. (NASDAQ:OMCL) Q2 2023 Earnings Call Transcript
August 2, 2023 | gurufocus.com
Omnicell Inc: A Healthcare Stock with Good Outperformance Potential
August 2, 2023 | msn.com
Piper Sandler Downgrades Omnicell (OMCL)
August 2, 2023 | finance.yahoo.com
Omnicell (OMCL) Q2 Earnings and Revenues Top, '23 View Raised
August 2, 2023 | finance.yahoo.com
Q2 2023 Omnicell Inc Earnings Call
August 1, 2023 | finance.yahoo.com
Omnicell (OMCL) Surpasses Q2 Earnings and Revenue Estimates
August 1, 2023 | msn.com
Benchmark Reiterates Omnicell (OMCL) Buy Recommendation
August 1, 2023 | finance.yahoo.com
Omnicell Announces Second Quarter 2023 Results
July 21, 2023 | msn.com
Wells Fargo Downgrades Omnicell (OMCL)
July 20, 2023 | msn.com
Omnicell downgraded at Wells Fargo citing risks to YTD rally
July 20, 2023 | markets.businessinsider.com
4 Analysts Have This to Say About Omnicell
July 18, 2023 | barrons.com
Omnicell Inc.
July 13, 2023 | benzinga.com
Keybanc Maintains Overweight on Omnicell, Raises Price Target to $80
July 13, 2023 | msn.com
Keybanc Maintains Omnicell (OMCL) Overweight Recommendation
July 12, 2023 | finance.yahoo.com
Omnicell to Release Second Quarter 2023 Financial Results on August 1, 2023
July 11, 2023 | finance.yahoo.com
Omnicell Appoints Bobby Ghoshal to Board of Directors
See More Headlines
Receive OMCL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Omnicell and its competitors with MarketBeat's FREE daily newsletter.

OMCL Company Calendar

Last Earnings
8/01/2023
Today
9/25/2023
Next Earnings (Estimated)
11/01/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Electronic computers
Sub-Industry
Health Care Technology
Sector
Medical
Current Symbol
NASDAQ:OMCL
CUSIP
68213N10
CIK
926326
Web
www.omnicell.com
Phone
(877) 415-9990
Fax
847-596-3402
Employees
4,230
Year Founded
1992

Price Target and Rating

Average Stock Price Forecast
$68.75
High Stock Price Forecast
$88.00
Low Stock Price Forecast
$54.00
Forecasted Upside/Downside
+41.8%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
7 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
66.44
P/E Growth
7.3
Net Income
$5.65 million
Net Margins
-1.88%
Pretax Margin
-2.20%
Return on Equity
4.47%
Return on Assets
2.31%

Debt

Debt-to-Equity Ratio
0.49
Current Ratio
2.38
Quick Ratio
2.03

Sales & Book Value

Annual Sales
$1.30 billion
Price / Sales
1.69
Cash Flow
$4.08 per share
Price / Cash Flow
11.88
Book Value
$25.52 per share
Price / Book
1.90

Miscellaneous

Outstanding Shares
45,210,000
Free Float
44,032,000
Market Cap
$2.19 billion
Optionable
Optionable
Beta
0.84

Social Links

A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Randall A. LippsMr. Randall A. Lipps (Age 66)
    Founder, Exec. Chairman, Pres & CEO
    Comp: $1.2M
  • Mr. Corey J. Manley
    Exec. VP and Chief Legal & Admin. Officer
  • Mr. Nchacha Etta (Age 52)
    Exec. VP & CFO
  • Ms. Minoo Mortazavi
    Sr. VP of Global Operations
  • Mr. Joseph Brian SpearsMr. Joseph Brian Spears (Age 63)
    Sr. VP, Chief Accounting Officer & Corp. Controller
  • Mr. Virad Gupta
    Sr. VP & CTO
  • Mr. Giri Chodavarapu
    Sr. VP & Chief Information Officer
  • Ms. Kathleen Nemeth
    Sr. VP of Investor Relations
  • Mr. Maximo Rocha
    Sr. VP & Chief People Officer
  • Mr. Jorge R. Taborga (Age 64)
    Exec. VP of Engineering & Integration Management Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













OMCL Stock - Frequently Asked Questions

Should I buy or sell Omnicell stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last year. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OMCL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMCL, but not buy additional shares or sell existing shares.
View OMCL analyst ratings or view top-rated stocks.

What is Omnicell's stock price forecast for 2023?

7 Wall Street analysts have issued 12 month price objectives for Omnicell's stock. Their OMCL share price forecasts range from $54.00 to $88.00. On average, they anticipate the company's share price to reach $68.75 in the next twelve months. This suggests a possible upside of 41.8% from the stock's current price.
View analysts price targets for OMCL or view top-rated stocks among Wall Street analysts.

How have OMCL shares performed in 2023?

Omnicell's stock was trading at $50.42 at the start of the year. Since then, OMCL shares have decreased by 3.8% and is now trading at $48.50.
View the best growth stocks for 2023 here.

When is Omnicell's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our OMCL earnings forecast.

How were Omnicell's earnings last quarter?

Omnicell, Inc. (NASDAQ:OMCL) posted its earnings results on Tuesday, August, 1st. The company reported $0.29 EPS for the quarter, beating analysts' consensus estimates of ($0.01) by $0.30. The company earned $298.97 million during the quarter, compared to the consensus estimate of $285.25 million. Omnicell had a negative net margin of 1.88% and a positive trailing twelve-month return on equity of 4.47%.

What ETFs hold Omnicell's stock?

ETFs with the largest weight of Omnicell (NASDAQ:OMCL) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), ROBO Global Healthcare Technology and Innovation ETF (HTEC) and Global X Robotics & Artificial Intelligence ETF (BOTZ).iShares U.S. Medical Devices ETF (IHI).

What guidance has Omnicell issued on next quarter's earnings?

Omnicell updated its FY23 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of $1.75-$2.00 for the period, compared to the consensus estimate of $1.68. The company issued revenue guidance of $1.16-$1.20 billion, compared to the consensus revenue estimate of $1.18 billion.

What is Randall A. Lipps' approval rating as Omnicell's CEO?

150 employees have rated Omnicell Chief Executive Officer Randall A. Lipps on Glassdoor.com. Randall A. Lipps has an approval rating of 68% among the company's employees.

What other stocks do shareholders of Omnicell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicell investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Adobe (ADBE), Micron Technology (MU), NVIDIA (NVDA), Applied Materials (AMAT), Alibaba Group (BABA) and Intel (INTC).

What is Omnicell's stock symbol?

Omnicell trades on the NASDAQ under the ticker symbol "OMCL."

Who are Omnicell's major shareholders?

Omnicell's stock is owned by a variety of retail and institutional investors. Top institutional investors include Clearbridge Investments LLC (2.97%), Conestoga Capital Advisors LLC (2.48%), Champlain Investment Partners LLC (2.23%), Geneva Capital Management LLC (2.22%), Geode Capital Management LLC (2.06%) and Dimensional Fund Advisors LP (1.88%). Insiders that own company stock include Christine Marie Mellon, Dan S Johnston, James T Judson, Joanne B Bauer, Joseph Brian Spears, Peter J Kuipers, Randall A Lipps, Robin Gene Seim and Scott Peter Seidelmann.
View institutional ownership trends.

How do I buy shares of Omnicell?

Shares of OMCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Omnicell's stock price today?

One share of OMCL stock can currently be purchased for approximately $48.50.

How much money does Omnicell make?

Omnicell (NASDAQ:OMCL) has a market capitalization of $2.19 billion and generates $1.30 billion in revenue each year. The company earns $5.65 million in net income (profit) each year or ($0.52) on an earnings per share basis.

How many employees does Omnicell have?

The company employs 4,230 workers across the globe.

Does Omnicell have any subsidiaries?
The following companies are subsidiares of Omnicell: 340B Investment LLC, 340B Link Business, 340B Link LLC, 340B Solutions LLC, Aesynt, Ateb Inc., FDS Amplicare, FDS Amplicare Company, FDS Inc., FDS Insurance Agency Inc., Flavma Inc., InPharmics, MTS Medication Technologies Inc., MTS Medication Technologies Inc., MTS Packaging Systems Inc., MarkeTouch Media LLC, MarkeTouch Media LLC, MedPak Holdings Inc., Omnicell (Beijing) Technology Co. Ltd, Omnicell B.V., Omnicell GmbH, Omnicell India Private Limited, Omnicell International LLC, Omnicell Limited, Omnicell Pty Ltd, Omnicell S.r.l., Omnicell SAS, ReCept Cityview LLC, ReCept F&M LLC, ReCept Group Inc., ReCept Healthcare Services L.P., ReCept Holdings Inc., ReCept LLC, ReCept One LLC, ReCept Pharmacy, ReCept Pharmacy L.P., RxInnovation Inc., and ateb Inc..
Read More
How can I contact Omnicell?

Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The official website for the company is www.omnicell.com. The company can be reached via phone at (877) 415-9990, via email at ir@omnicell.com, or via fax at 847-596-3402.

This page (NASDAQ:OMCL) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -